MARKER THERAPEUTICS, INC. (MRKR) Revenue 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.5MFY2025 · since FY2017: $183,064 → $3.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.5M | -46.2% |
| FY2024 | $6.6M | +99.1% |
| FY2023 | $3.3M | -5.8% |
| FY2022 | $3.5M | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $500,000 | +134.5% |
| FY2019 | $213,194 | +3.5% |
| FY2018 | $205,994 | +12.5% |
| FY2017 | $183,064 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Operating cash flowMRKR Free cash flowMRKR Capital expendituresMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →